P. Lauren Silvernail's Insider Trades & SAST Disclosures
P. Lauren Silvernail's most recent trade in Dynavax Technologies Corp. was a trade of 42,750 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 3, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern P. Lauren Silvernail.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dynavax Technologies Corp. | Lauren P. Silvernail | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 42,750 | 42,750 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | Lauren P. Silvernail | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 8,636 | 8,636 | - | - | Restricted Stock Unit | |
| Harrow Health Inc | Lauren P. Silvernail | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 8,347 | 8,347 | - | - | RSU | |
| Harrow Health Inc | P. Lauren Silvernail | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2024 | 3,119 | 3,119 | - | - | RSU | |
| Harpoon Therapeutics Inc | Lauren P. Silvernail | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 23,000 | 23,000 | - | - | Director Stock Option (Right to Buy) | |
| Harpoon Therapeutics Inc | Lauren P. Silvernail | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2022 | 20,335 | 20,335 | - | - | Director Stock Option (right to buy) | |
| Evolus Inc | Lauren P. Silvernail | See Remarks | Sale of securities on an exchange or to another person at price $ 12.42 per share. | 17 May 2022 | 52,015 | 141,571 (0%) | 0% | 12.4 | 646,026 | Common Stock |
| Evolus Inc | Lauren P. Silvernail | See Remarks | Sale of securities on an exchange or to another person at price $ 13.92 per share. | 17 May 2022 | 16,189 | 193,586 (0%) | 0% | 13.9 | 225,354 | Common Stock |
| Evolus Inc | Lauren P. Silvernail | See Remarks | Sale of securities on an exchange or to another person at price $ 9.73 per share. | 08 Mar 2022 | 10,192 | 209,775 (0%) | 0% | 9.7 | 99,121 | Common Stock |
| Evolus Inc | Lauren P. Silvernail | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2022 | 77,640 | 77,640 | - | - | Stock Option (Right to Buy) | |
| Evolus Inc | Lauren P. Silvernail | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2022 | 53,571 | 219,967 (0%) | 0% | 0 | Common Stock | |
| Evolus Inc | Lauren P. Silvernail | See Remarks | Sale of securities on an exchange or to another person at price $ 11.18 per share. | 10 Aug 2021 | 14,293 | 166,396 (0%) | 0% | 11.2 | 159,774 | Common Stock |
| Evolus Inc | Lauren P. Silvernail | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2021 | 90,000 | 180,689 (0%) | 0% | 0 | Common Stock | |
| Evolus Inc | Lauren P. Silvernail | See Remarks | Sale of securities on an exchange or to another person at price $ 7.46 per share. | 25 Jan 2021 | 2,699 | 90,689 (0%) | 0% | 7.5 | 20,135 | Common Stock |
| Evolus Inc | Lauren P. Silvernail | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2020 | 40,000 | 93,388 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges